Hospira (HSP) Recalls Two Drugs Over Contamination Issue, FDA Says
Tweet Send to a FriendGet Alerts HSP Hot Sheet
Down)
Trade HSP Now!
Hospira, Inc. (NYSE: HSP) is lower on the session following headlines that the company recalled two drugs over potential contamination risk.
According to the FDA, about 145,000 vials of nalbuphine were recalled on November 21st and 120,000 vials of lidocaine injections were recalled on October 4th. Malbuphine was recalled over loose or missing caps while lidocaine had reports of particulate matter embedded in a glass wall of the vials.
With its quarterly conference call on November 7th, Hospira said it was making progress with remediation over the recalls.
Shares are down 0.8 percent Friday.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
According to the FDA, about 145,000 vials of nalbuphine were recalled on November 21st and 120,000 vials of lidocaine injections were recalled on October 4th. Malbuphine was recalled over loose or missing caps while lidocaine had reports of particulate matter embedded in a glass wall of the vials.
With its quarterly conference call on November 7th, Hospira said it was making progress with remediation over the recalls.
Shares are down 0.8 percent Friday.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Crash in American Electric Power (AEP) & NextEra Energy (NEE) Adds to Jitters
- Biogen Idec (BIIB) Appoints Spyros Artavanis-Tsakonas as CSO
- Dover (DOV) Latest Diversified Industrial to Announce Streamlining; More to Follow?
Create E-mail Alert Related Categories
FDA, Insiders' BlogRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
